BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
1006 results:

  • 1. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).
    Taghizadeh M; Jafari-Koshki T; Jafarlou V; Raeisi M; Alizadeh L; Roosta Y; Matin S; Jabari R; Sur D; Karimi A
    BMC Cancer; 2024 Apr; 24(1):484. PubMed ID: 38627675
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.
    Wang F; Jin Y; Wang M; Luo HY; Fang WJ; Wang YN; Chen YX; Huang RJ; Guan WL; Li JB; Li YH; Wang FH; Hu XH; Zhang YQ; Qiu MZ; Liu LL; Wang ZX; Ren C; Wang DS; Zhang DS; Wang ZQ; Liao WT; Tian L; Zhao Q; Xu RH
    Nat Med; 2024 Apr; 30(4):1035-1043. PubMed ID: 38438735
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical efficacy of acupuncture in treating postoperative gastrointestinal dysfunction of colorectal cancer, a systematic review and meta analysis.
    Zhou T; Wang S; Fan BJ; Zhang LX; Hu SH; Hou W
    Zhen Ci Yan Jiu; 2024 Feb; 49(2):208-219. PubMed ID: 38413043
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
    Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
    Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
    Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
    J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
    Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
    Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
    Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
    EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
    Jiang X; Wang S; Liang Q; Liu Y; Liu L
    Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High Protein Oral Nutritional Supplements Enable the Majority of cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-cancer treatment: A Randomised Controlled Parallel-Group Study.
    Dingemans AM; van Walree N; Schramel F; Soud MY; Baltruškevičienė E; Lybaert W; Veldhorst M; van den Berg CA; Kaasa S
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140289
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Outcomes of metachronous para-aortic lymphadenectomy in colorectal cancer: a systematic review of the literature.
    Onafowokan OO; Redfern J; Patel A; Satyadas T; Baltatzis M
    Langenbecks Arch Surg; 2023 Dec; 409(1):4. PubMed ID: 38091090
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lactobacillus paracasei R3 Alleviates Tumor Progression in Mice with colorectal cancer.
    Chen T; Li B; Zheng K; Liu Y; Zhang Z; Hu H; Qian G; Jiang J
    Curr Microbiol; 2023 Dec; 81(1):38. PubMed ID: 38091085
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of immune checkpoint inhibitors for patients with prostate cancer: a systematic review and meta-analysis.
    Noori M; Azizi S; Mahjoubfar A; Abbasi Varaki F; Fayyaz F; Mousavian AH; Bashash D; Kardoust Parizi M; Kasaeian A
    Front Immunol; 2023; 14():1181051. PubMed ID: 38022569
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of outcomes between surgical treatment of colorectal cancer metastatic to the liver and the peritoneum: Review of the literature.
    Cos H; Shen P
    J Surg Oncol; 2024 Jan; 129(1):85-90. PubMed ID: 37990864
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Surgical cancer Care in Safety-Net Hospitals: a Systematic Review.
    Wong P; Victorino GP; Sadjadi J; Knopf K; Maker AV; Thornblade LW
    J Gastrointest Surg; 2023 Dec; 27(12):2920-2930. PubMed ID: 37968551
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence of alexithymia in cancer patients: a systematic review and meta-analysis.
    Liu Y; Du Q; Jiang Y
    Support Care Cancer; 2023 Nov; 31(12):675. PubMed ID: 37932546
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
    Pietrantonio F; Bergamo F; Rossini D; Ghelardi F; De Grandis MC; Germani MM; Barsotti G; Formica V; Frassineti GL; Boscolo G; Cinieri S; Di Donato S; Antonuzzo L; Antoniotti C; Ambrosini M; Piva VM; Nichetti F; Fassan M; Cremolini C; Lonardi S
    Eur J Cancer; 2023 Dec; 195():113396. PubMed ID: 37924647
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer.
    Zheng HD; Hu YH; Ye K; Xu JH
    World J Gastroenterol; 2023 Oct; 29(39):5483-5493. PubMed ID: 37900997
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
    Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 51.